Metabolism of human prothrombin and fibrinogen in patients with thrombocytosis secondary to myeloproliferative states.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000469:Alkaline Phosphatase / Q000097:blood; D001772:Blood Cell Count; D001779:Blood Coagulation Factors / Q000032:analysis; D001780:Blood Coagulation Tests; D001792:Blood Platelets; D002066:Busulfan / Q000627:therapeutic use; D005340:Fibrinogen / Q000378:metabolism*; D006400:Hematocrit; D006801:Humans; D007456:Iodine Isotopes; D007962:Leukocytes / Q000201:enzymology; D008875:Middle Aged; D009196:Myeloproliferative Disorders / Q000150:complications*; D011087:Polycythemia Vera / Q000150:complications; D055728:Primary Myelofibrosis / Q000150:complications; D011516:Prothrombin / Q000378:metabolism*; D013163:Splenomegaly / Q000209:etiology; D013920:Thrombocythemia, Essential / Q000150:complications; D013922:Thrombocytosis / Q000188:drug therapy / Q000209:etiology / Q000378:metabolism*
D001779:Blood Coagulation Factors; D007456:Iodine Isotopes; D011516:Prothrombin; D005340:Fibrinogen; D000469:Alkaline Phosphatase; D002066:Busulfan